ODDB.org: Open Drug Database

Novartis Pharma Schweiz AG - Ilaris, Injektionslösung

Swissmedic Registration	66191	Sequence	01
Product name	Ilaris	Description	Injektionslösung
ATC-Classification	L04AC08	ATC-Description	Canakinumab
Introduction of Sequence	15.05.2017

Composition

canakinumabum 150 mg, mannitolum, histidinum aut histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Canakinumabum	150 mg/ml

BAG: Active Agent	Dose
Canakinumabum	150 mg

Inactive agents
Histidinum aut Histidini Hydrochloridum Monohydricum
Mannitol
Polysorbatum 80

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		10377.33	10954.95	A	SL	No

2025	©ywesee GmbH